MedTrace Logo

Association Between COVID-19 and UTIs Caused by ESBL Organism in Infants

NCT05630326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5600

Last updated 2023-07-27

No results posted yet for this study

Summary

Urinary tract infections (UTIs) in infants and young children are one of the most common bacterial infections, usually febrile illness without source, frequently due to Enterobacteriaceae, mainly Escherichia coli.

Multidrug-resistant organisms including extended-spectrum beta-lactamase (ESBL) producing bacteria are becoming more prevalent. Due to the risk factors of ESBL-producing organisms in community-acquired (CA)-UTIs in infants in QATAR and Arab countries are still not studied because of the limited therapeutic options. hence, the importance of this study is to get knowledge about how to decrease the rapidly increasing in ESBL- producing bacteria, in infants, and to use antibiotics in a suitable guideline.so, The aim of this retrospective case-control study is to determine the clinical manifestations, and investigations of urinary tract infections among infants and the association with COVID-19 infection, in pediatric emergency centers at Hamad General Hospital - Qatar. From 1st January 2015 till 1st January 2022.

Conditions

  • Renal Insufficiency

Interventions

OTHER

comparing, prevalence

Comparing infants with UTIs caused by ESBL organism, or non ESBL organism.

OTHER

assessment

comparing infants with UTIs caused by ESBL organism, or non ESBL organism.

OTHER

association

comparing ESBLUTI with COVID-19 and ESBL UTI without COVID-19

OTHER

evaluation

comparing ESBLUTI with COVID-19 and ESBL UTI without COVID-19

Sponsors & Collaborators

  • Hamad Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Mahmoud Alhandi Omar Helal · Hamad Medical Corporation

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-07-01
Completion
2023-07-20

Countries

  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05630326 on ClinicalTrials.gov